Drug Type Small molecule drug |
Synonyms GMC-1111 |
Target |
Action agonists |
Mechanism D2 receptor agonists(Dopamine D2 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC16H25Cl2N3S |
InChIKeyZNHLCGFCYLKGOA-UHFFFAOYSA-N |
CAS Registry254885-69-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Parkinson Disease | Discovery | United States | - | |
| Schizophrenia | Discovery | United States | - |





